Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aerosolized esketamine to reduce postpartum depression after cesarean section
ChiCTR2000038855Phase 4Recruiting
- Sponsor
- Chenzhou First People's Hospital Department of Anesthesiology
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in postpartum depression (PPD) comparing Esketamine nebulization with Placebo nebulization (water for injection) (2 arms). Primary endpoint: Depression score. Started Nov 2020; status: recruiting.
02
Drugs
esketamine
03
Conditions
postpartum depression (PPD)
Beyond the preview
Go deeper on ChiCTR2000038855.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000038855.